| Trial ID: | L5251 |
| Source ID: | NCT00470990
|
| Associated Drug: |
Gnrh Antagonist (Acyline)
|
| Title: |
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypogonadism
|
| Interventions: |
DRUG: GnRH antagonist (Acyline)
|
| Outcome Measures: |
Primary: insulin sensitivity, 2 timepoints: with a normal serum testsoterone and in a castrate state of low serum testoserone | Secondary: body composition, 2 timepoints: with a normal serum testsoterone and in a castrate state of low serum testoserone
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Collaborators: American Diabetes Association
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose:
|
| Start Date: |
2002-10
|
| Completion Date: |
2008-06
|
| Results First Posted: |
|
| Last Update Posted: |
2011-04-20
|
| Locations: |
Massachusetts General Hospital, Boston, Massachusetts, 02143, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00470990
|
